Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials
Abstract Background Non-alcoholic fatty liver disease (NAFLD) is a common liver disease that may progress into, in the absence of proper treatment, severe liver damage. While the optimal pharmacotherapy for NAFLD remains uncertain and the adherence to lifestyle interventions is challenging, the use...
Saved in:
Main Authors: | Zuanji Liang (Author), Xianwen Chen (Author), Junnan Shi (Author), Hao Hu (Author), Yan Xue (Author), Carolina Oi Lam Ung (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications
by: Zuanji Liang, et al.
Published: (2021) -
Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design
by: Xianwen Chen, et al.
Published: (2023) -
An evaluation of randomized controlled trials on nutraceuticals containing traditional Chinese medicines for diabetes management: a systematic review
by: Junnan Shi, et al.
Published: (2019) -
Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a systematic literature review of randomized controlled trials
by: Jingya Yang, et al.
Published: (2023) -
Benchmarking Drug Regulatory Systems for Capacity Building: An Integrative Review of Tools, Practice, and Recommendations
by: Junnan Shi, et al.
Published: (2023)